Dermatology And Therapy

Dermatology and Therapy is an international, open access, peer-reviewed, rapid publication journal (peer review in 2 weeks, published 3–4 weeks from acceptance). The journal is dedicated to the publication of high-quality clinical (all phases), observational, real-world, and health outcomes research around the discovery, development, and use of dermatological therapies. Studies relating to diagnosis, pharmacoeconomics, public health and epidemiology, quality of life, and patient care, management, and education are also encouraged.

Areas of focus include, but are not limited to all clinical aspects of dermatology, such as skin pharmacology; skin development and aging; prevention, diagnosis, and management of skin disorders and melanomas; research into dermal structures and pathology; and all areas of aesthetic dermatology, including skin maintenance, dermatological surgery, and lasers.

The journal is of interest to a broad audience of pharmaceutical and healthcare professionals and publishes original research, reviews, case reports/case series, trial protocols, and short communications. Dermatology and Therapy will consider all scientifically sound research be it positive, confirmatory or negative data. Submissions are welcomed whether they relate to an International and/or a country-specific audience, something that is crucially important when researchers are trying to target more specific patient populations. This inclusive approach allows the journal to assist in the dissemination of quality research, which may be considered of insufficient interest by other journals. The journal appeals to a global audience and receives submissions from all over the world.

《皮肤病学与治疗学》是一本国际性、开放获取、同行评审、快速出版的期刊（同行评审 2 周，接受后 3-4 周内出版）。该期刊致力于发表围绕皮肤病学疗法的发现、开发和使用的高质量临床（所有阶段）、观察性、真实世界和健康结果研究。还鼓励与诊断、药物经济学、公共卫生和流行病学、生活质量以及患者护理、管理和教育相关的研究。

重点领域包括但不限于皮肤病学的所有临床方面，例如皮肤药理学；皮肤发育和衰老；皮肤病和黑色素瘤的预防、诊断和管理；皮肤结构和病理学研究；以及美容皮肤科的所有领域，包括皮肤保养、皮肤外科和激光。

该期刊受到广大医药和医疗保健专业人士的关注，并发表原创研究、评论、病例报告/病例系列、试验方案和简短通讯。皮肤病学和治疗学将考虑所有科学合理的研究，无论是正面、确认性还是负面数据。无论投稿涉及国际和/或特定国家的受众，我们都欢迎投稿，当研究人员试图针对更具体的患者群体时，这一点至关重要。这种包容性方法使该期刊能够协助传播其他期刊可能认为不够有趣的高质量研究。该期刊吸引了全球读者，并收到来自世界各地的投稿。

该刊已被国际权威数据库SCIE收录，该刊致力于发表经过严格同行评审的高质量原创文章，反映Medicine-Dermatology领域的新进展、新技术、新成果，促进该领域科研交流和科研成果转化。该刊2023年影响因子为3.5，平均审稿速度为 6 Weeks ，近四年来没有被列入预警名单。如果您需要投稿发表服务及指导，可以联系我们的客服老师，我们专业专注服务期刊投稿协助10年，为您提供期刊投稿个性化定制服务，并且我们确保严格保密您的个人信息及稿件内容。